chronic disease related knowledge
Release time:
2020-08-14
chronic disease related knowledge
chronic disease is chronic non-communicable disease, which does not specifically refer to a certain disease, but is a general general term for a kind of disease with hidden onset, long course of disease and prolonged illness, lack of definite evidence of infectious biological etiology, complex etiology, and some diseases that have not yet been fully confirmed. Common chronic diseases mainly include cardiovascular and cerebrovascular diseases, malignant tumors, diabetes, and chronic respiratory diseases. The central cerebrovascular diseases include hypertension, stroke and coronary heart disease.
Chronic diseases have the characteristics of high medical costs and great harm. Based on this, China's medical insurance provides subsidies for chronic diseases. There are a total of 31 chronic disease subsidy diseases in China, namely: hypertension, diabetes, liver cirrhosis, rheumatic heart disease, pulmonary heart disease, chronic viral hepatitis, tuberculosis, lymph node tuberculosis, hyperthyroidism, hypothyroidism, rheumatoid arthritis, hemolytic anemia, leukemia, recurrent aphthous oral ulcer, coronary heart disease ( only includes myocardial infarction and angina pectoris ) , primary chronic obstructive pulmonary disease COPD (aplastic anemia, muscle fibrosis, chronic kidney disease (CKD) stage III and above systemic lupus erythematosus, severe osteoporosis with multiple fractures, Behcet's disease, aggressive periodontitis, oral lichen planus, psoriasis, varicose veins of lower extremities, femoral head necrosis, Parkinson's disease, malignant tumor, schizophrenia.
Spike Pharmacy Chronic Disease Life Hall currently mainly provides services for diabetic patients, and other chronic disease services will be expanded when conditions are ripe.
Major Pharmacy Chronic Disease Life Hall Member Rights:
● Member File : Diabetic Patients Can Enjoy Membership Rights by Handling "Health File" with Valid Proof (Membership Card, Case, Medical Insurance Card, Shopping Receipt, etc.).
● Preferential Day for Chronic Disease Members: 8 and 18 of each month are special price days for diabetes filing members. Members can enjoy special price activities for all kinds of diabetes products (not at the same time as chronic disease health cards).
● Exclusive for special offers: diabetes filing members can enjoy special offers, special bundled packages, etc.
● Diabetes Education Advisory Service: The Diabetes Education Commissioner provides one-on-one counseling service to members to assist them in developing personalized solutions.
● Free blood glucose monitoring: According to the needs of different blood glucose monitoring points, 8 free blood glucose monitoring is provided every month.
● Blood Glucose Meter Donation Activity: A blood glucose meter (designated) can be obtained free of charge if the accumulated consumption of diabetes drugs 200 yuan.
● Exclusive special price for blood glucose test paper: diabetes filing members can enjoy a discount of 8 for blood glucose test paper.
● Free Health Education: Members regularly receive free health knowledge books and attend health knowledge lectures.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page